Atraric acid - HY-N2908
Nur noch %1 verfügbar
Catalog #
HY-N2908
Ab
31,00 €
Atraric acid (Methyl atrarate) is a specific androgen receptor (AR) antagonist with anti-inflammatory and anticancer effects. Atraric acid represses the expression of the endogenous prostate specific antigen gene in both LNCaP and C4-2 cells. Atraric acid can also inhibit the synthesis of NO and cytokine, and suppress the MAPK-NFκB signaling pathway. Atraric acid can be used to research prostate diseases and inflammatory diseases[1][2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-N2908/Atraric-acid-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | COVID-19-immunoregulation |
| Alternative Names | Methyl atrarate |
| CAS | 4707-47-5 |
| Storage | RT, stored under nitrogen |
| MWT | 196.20 |
| Solubility | DMSO : 100 mg/mL (ultrasonic) |
| Clinical Information | No Development Reported |
| Target | Androgen Receptor;NF-κB;NO Synthase;p38 MAPK |
| Application: | COVID-19-immunoregulation |
|---|